Search - tctmd.com

Displaying 721 - 740 of 999

Sort: Relevancy | Date

Presentation TVT 2016

A New CT-Based Diagnostic Schema for Classifying Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

Presenter: Hasan Jilaihawi

June 16, 2016

Presentation TVT 2016

Epidemiology of Bicuspid Aortic Valve Disease in Younger Patients

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Presenter: Martin B. Leon

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Presentation SOLACI 2016

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presenter: Martin B. Leon

June 10, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Evolution of TAVR in Denmark May Have Implications for Other Countries

L.A. McKeown

June 06, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Yael L. Maxwell

May 19, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

Presentation

TAVR Compared with SAVR in Low-Risk Patients

Presenter: Stefano Rosato

May 16, 2016

News Daily News

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Todd Neale

May 16, 2016

News Daily News

Italian Registry Cautions Against TAVR in Low-Risk Patients

L.A. McKeown

May 16, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Daily News

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Todd Neale

May 12, 2016

Advertisement

A New CT-Based Diagnostic Schema for Classifying Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

Epidemiology of Bicuspid Aortic Valve Disease in Younger Patients

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Evolution of TAVR in Denmark May Have Implications for Other Countries

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

TAVR Compared with SAVR in Low-Risk Patients

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Italian Registry Cautions Against TAVR in Low-Risk Patients

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content